Abstract
Sessile serrated adenomas are now recognised as precursor lesions of a substantial subset of colorectal cancers arising via a so-called “serrated pathway”. However, their biological markers remain to be defined. The aim of our study was to identify differentially expressed genes in sessile serrated adenomas and conventional adenomas. Gene expression analysis demonstrated molecular differences between polyp types. Further studies using quantitative real-time polymerase chain reaction on cathepsin E (CTSE) demonstrated a significantly (p < 0.05) higher expression in sessile serrated adenomas as compared to hyperplastic polyp and tubular adenomas. Trefoil Factor 1 showed the same trend of expression for sessile serrated adenomas as compared to hyperplastic polyps and was significantly higher in both polyps compared to tubular adenomas. Immunohistochemistry for both proteins demonstrated strong cytoplasmic staining of abnormal crypts in all sessile serrated adenomas, while staining in tubular adenomas and hyperplastic polyps was absent or weak and focal. BRAF and KRAS mutation analysis were employed to further validate polyp discrimination. The findings demonstrated the positive association of the BRAF mutation, V600E, with sessile serrated adenomas and KRAS mutations with tubular adenomas (p < 0.05). This study demonstrates the over-expression in CTSE, in particular, and TFF1 in sessile serrated adenomas compared to both hyperplastic polyps and tubular adenomas.
Similar content being viewed by others
References
Iino H, Simms L, Young J et al (2000) DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 47:37–42
Jass JR, Iino H, Ruszkiewicz A et al (2000) Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47:43–49
Hawkins NJ, Ward RL (2001) Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93:1307–1313
Jass JR (2001) Serrated route to colorectal cancer: back street or super highway? J Pathol 193:283–285
Young J, Biden KG, Simms LA et al (2001) HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 98:265–270
Chan AO, Issa JP, Morris JS et al (2002) Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160:529–536
Park SJ, Rashid A, Lee JH et al (2003) Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162:815–822
Jass JR (1999) Serrated adenoma and colorectal cancer. J Pathol 187:499–502
Jass JR (2003) Serrated adenoma of the colorectum: a lesion with teeth. Am J Pathol 162:705–708
Torlakovic E, Skovlund E, Snover DC et al (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27:65–81
Longacre TA, Fenoglio-Preiser CM (1990) Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14:524–537
Sandmeier D, Seelentag W, Bouzourene H (2007) Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch 450:613–618
Tuppurainen K, Makinen JM, Junttila O et al (2005) Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 207:285–294
Laiho P, Kokko A, Vanharanta S et al (2007) Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26:312–320
Makinen MJ (2007) Colorectal serrated adenocarcinoma. Histopathology 50:131–150
O’Brien MJ, Yang S, Mack C et al (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491–1501
Kambara T, Simms LA, Whitehall VL et al (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53:1137–1144
Jass JR (2004) Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2:1–8
Jass JR, Baker K, Zlobec I et al (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer. Histopathology 49:121–131
Farris AB, Misdraji J, Srivastava A et al (2008) Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 32:30–35
Smith FB, Aksenov S (2007) Potential role of nuclear appearance in pathologic recognition and delimitation of sessile serrated polyps of the colon: a karyometric study. Anal Quant Cytol Histol 29:326–332
Torlakovic EE, Gomez JD, Driman DK et al (2008) Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32:21–29
Goldstein NS, Bhanot P, Odish E et al (2003) Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119:778–796
Snover DC, Jass JR, Fenoglio-Preiser C et al (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124:380–391
Yang YH, Buckley MJ, Speed TP (2001) Analysis of cDNA microarray images. Brief Bioinform 2:341–349
Ritchie ME (2004) Quantitative quality control and background correction for two-color microarray data. Melbourne, University of Melbourne. Ph.D. thesis:1–139
Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
Yang YH, Dudoit S, Luu P et al (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15
Di Fiore F, Blanchard F, Charbonnier F et al (2007) Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer 96:1166–1169
Zaidi N, Kalbacher H (2008) Cathepsin E: a mini review. Biochem Biophys Res Commun 367:517–522
Paulli M, Feller AC, Boveri E et al (1994) Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans’ cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders. Virchows Arch 424:601–606
Chain BM, Free P, Medd P et al (2005) The expression and function of cathepsin E in dendritic cells. J Immunol 174:1791–1800
Azuma T, Pals G, Mohandas TK et al (1989) Human gastric cathepsin E. Predicted sequence, localization to chromosome 1, and sequence homology with other aspartic proteinases. J Biol Chem 264:16748–16753
Fiocca R, Villani L, Tenti P et al (1990) The foveolar cell component of gastric cancer. Hum Pathol 21:260–270
Sessa F, Bonato M, Frigerio B et al (1990) Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98:1655–1665
Azuma T, Hirai M, Ito S et al (1996) Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report. Int J Cancer 67:492–497
Uno K, Azuma T, Nakajima M et al (2000) Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 15:1333–1338
Tenti P, Romagnoli S, Silini E et al (1994) Cervical adenocarcinomas express markers common to gastric, intestinal, and pancreatobiliary epithelial cells. Pathol Res Pract 190:342–349
Mota F, Kanan JH, Rayment N et al (1997) Cathepsin E expression by normal and premalignant cervical epithelium. Am J Pathol 150:1223–1229
Finzi G, Cornaggia M, Capella C et al (1993) Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing. Histochemistry 99:201–11
Wong NA, Herriot M, Rae F (2003) An immunohistochemical study and review of potential markers of human intestinal M cells. Eur J Histochem 47:143–150
Busquets L, Guillen H, DeFord ME et al (2006) Cathepsin E is a specific marker of dysplasia in APC mouse intestine. Tumour Biol 27:36–42
Jakowlew SB, Breathnach R, Jeltsch JM et al (1984) Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 12:2861–2878
Nunez AM, Jakowlev S, Briand JP et al (1987) Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinology 121:1759–1765
Madsen J, Nielsen O, Tornoe I et al (2007) Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 55:505–513
Perry JK, Kannan N, Grandison PM et al (2008) Are trefoil factors oncogenic? Trends Endocrinol Metab 19:74–81
Rio MC, Chenard MP, Wolf C et al (1991) Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100:375–379
Playford RJ (1997) Trefoil peptides: what are they and what do they do? J R Coll Physicians Lond 31:37–41
Gronbaek H, Vestergaard EM, Hey H et al (2006) Serum trefoil factors in patients with inflammatory bowel disease. Digestion 74:33–39
Longman RJ, Poulsom R, Corfield AP et al (2006) Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem 54:1335–1348
Ren JL, Luo JY, Lu YP et al (2006) Molecular forms of trefoil factor 1 in normal gastric mucosa and its expression in normal and abnormal gastric tissues. World J Gastroenterol 12:7361–7364
Welter C, Theisinger B, Rio MC et al (1994) Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors. Int J Cancer 56:52–55
Tuna B, Sokmen S, Sarioglu S et al (2006) PS2 and HSP70 expression in rectal adenocarcinomas: an immunohistochemical investigation of 45 cases. Appl Immunohistochem Mol Morphol 14:31–36
Higashiyama M, Doi O, Kodama K et al (1996) Estimation of serum level of pS2 protein in patients with lung adenocarcinoma. Anticancer Res 16:2351–2355
Prasad NB, Biankin AV, Fukushima N et al (2005) Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 65:1619–1626
Hanby AM, Poulsom R, Singh S et al (1993) Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage. Am J Pathol 142:663–668
Mochizuka A, Uehara T, Nakamura T et al (2007) Hyperplastic polyps and sessile serrated ‘adenomas’ of the colon and rectum display gastric pyloric differentiation. Histochem Cell Biol 128:445–455
Owens SR, Chiosea SI, Kuan SF (2008) Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 21:660–669
Shousha S, Luqmani YA, Sannino P et al (1993) pS2 immunostaining of colorectal carcinoma. Mod Pathol 6:446–448
Rodrigues S, Rodrigue CM, Attoub S et al (2006) Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells. Oncogene 25:6628–6636
Rajagopalan H, Bardelli A, Lengauer C et al (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418:934
Yuen ST, Davies H, Chan TL et al (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451–6455
Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Yang S, Farraye FA, Mack C et al (2004) BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28:1452–1459
Chan TL, Zhao W, Leung SY et al (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63:4878–4881
Acknowledgements
The authors thank Kay Taylor, Gastroenterology Research Laboratory, SA Pathology, for her technical assistance with the immunohistochemistry and Nancy Brigs for her assistance with the statistical analysis. This study was supported by Cancer and Bowel Research Trust, SA, Australia.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caruso, M., Moore, J., Goodall, G.J. et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch 454, 291–302 (2009). https://doi.org/10.1007/s00428-009-0731-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-009-0731-0